CONNOR PRICE: Open Payments
NPI 1942887229 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 54 payments from 20 companies in 2025. Trend: 2023 $2,658 · 2024 $4,465 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $246 |
| Novo Nordisk Inc | 7 | $239 |
| Sequel Med Tech, LLC | 2 | $192 |
| Madrigal Pharmaceuticals | 4 | $156 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $143 |
| Lilly USA, LLC | 4 | $94 |
| BETA BIONICS, INC. | 9 | $89 |
| Amgen Inc. | 4 | $81 |
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| Radius Health, Inc. | 2 | $47 |
Products named: FREESTYLE LIBRE 3, TWIIST, REZDIFFRA, Ozempic, ISTURISA, iLet Bionic Pancreas, Wegovy, JARDIANCE.
Industry payments across NY — which companies pay providers there.
